Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Optimum Therapeutics for $163,657.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA121744-01 | Phase I | 163,657 | ||||||||
A SBIR Phase I contract was awarded to Optimum Therapeutics for $197,840.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA107998-01A1 | Phase I | 197,840 | ||||||||
A SBIR Phase I contract was awarded to Optimum Therapeutics for $248,174.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA134047-01A1 | Phase I | 248,174 | ||||||||
A SBIR Phase I contract was awarded to Optimum Therapeutics for $303,226.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA162448-01 | Phase I | 303,226 | ||||||||
A SBIR Phase I contract was awarded to Optimum Therapeutics for $495,504.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA103133-01 | Phase I | 495,504 | ||||||||
A SBIR Phase II contract was awarded to Optimum Therapeutics for $841,754.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA103133-03A1 | Phase II | 841,754 | ||||||||
A SBIR Phase I contract was awarded to Optimum Therapeutics for $600,314.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA107743-01 | Phase I | 600,314 | ||||||||
A SBIR Phase I contract was awarded to Optimum Therapeutics for $344,460.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR000356-01 | Phase I | 344,460 | ||||||||
A SBIR Phase II contract was awarded to Optimum Therapeutics for $1,375,700.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA107743-03 | Phase II | 1,375,700 |